About
CartiCure is an early-stage company dedicated to the development of cartilage repair products. CartiCure's technological platform generates original hyaline cartilage-producing cells to be transplanted into damaged joints, efficiently replenishing lesions in the articular cartilage. The company's first product, Cartimove, is designed for treatment of knee cartilage damage that results from trauma injuries. The company's next-generation product is targeted at the osteoarthritis market. The company is supported by the NGT High-Tech Incubator in Nazareth, Israel. Scientific work and ongoing animal trials are being conducted at the Faculty of Medicine at the Technion-Institute of Technology in Haifa, Israel. The company has successfully completed pre-clinical studies performed in large and small animals. It has a strong IP portfolio thatincludes a granted US patent.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is CartiCure's primary focus in product development?
- CartiCure is dedicated to developing cartilage repair products, specifically focusing on generating original hyaline cartilage-producing cells for transplantation into damaged joints.
- What is the status of CartiCure as of August 2017?
- CartiCure's status is inactive as of August 2017, according to startupim data.
- Where is CartiCure's headquarters located?
- CartiCure's headquarters is in Nof HaGalil, Israel.
- What is the name of CartiCure's first product and its intended use?
- CartiCure's first product is Cartimove, designed for the treatment of knee cartilage damage resulting from trauma injuries.
- Which market is CartiCure's next-generation product targeting?
- CartiCure's next-generation product is targeted at the osteoarthritis market.
- What kind of support does CartiCure receive in Israel?
- CartiCure is supported by the NGT High-Tech Incubator in Nazareth, Israel.
- Where are CartiCure's scientific work and animal trials being conducted?
- Scientific work and ongoing animal trials for CartiCure are being conducted at the Faculty of Medicine at the Technion-Institute of Technology in Haifa, Israel.
- Has CartiCure completed any pre-clinical studies?
- Yes, CartiCure has successfully completed pre-clinical studies performed in large and small animals.
- Does CartiCure possess any intellectual property?
- Yes, CartiCure has a strong IP portfolio that includes a granted US patent.
- Who is a known founder of CartiCure?
- Gila Maor is a known founder of CartiCure.